Plasma 8-iso-prostaglandin F_2α, a marker of oxidative stress, is increased in patients with acute myocardial infarction

References

• Thom T, Kannel W, Silbershatz S. Incidence, prevalence, and mortality of cardiovascular diseases in the United States. Hurst's the heart9th ed, RW Alexander, RC Schlant, V Fuster, R Roberts. McGraw Hill, New York 1998; 3
   Google Scholar
• Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 2003; 290: 891–897
   PubMed Web of Science ®Google Scholar
• Ridker PM, Morrow DA. C-reactive protein, inflammation, and coronary risk. Cardiol Clin 2003; 21: 315–325
   PubMedGoogle Scholar
• Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973–979
   PubMed Web of Science ®Google Scholar
• Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, Linton MF, Funk CD. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J Clin Invest 1999; 103: 1597–1604
   PubMed Web of Science ®Google Scholar
• Lusis AJ. Atherosclerosis. Nature 2000; 407: 233–241
   PubMed Web of Science ®Google Scholar
• Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868–874
   PubMed Web of Science ®Google Scholar
• Labarrere CA, Zaloga GP. C-reactive protein: From innocent bystander to pivotal mediator of atherosclerosis. Am J Med 2004; 117: 499–507
   PubMed Web of Science ®Google Scholar
• Yeh ET. CRP as a mediator of disease. Circulation 2004; 109: II11–II14
   PubMed Web of Science ®Google Scholar
• Tebo JM, Mortensen RF. Internalization and degradation of receptor bound C-reactive protein by U-937 cells: Induction of H2O2 production and tumoricidal activity. Biochim Biophys Acta 1991; 1095: 210–216
   PubMedGoogle Scholar
• Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, Li RK, Mickle DA, Verma S. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003; 107: 1783–1790
   PubMed Web of Science ®Google Scholar
• Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003; 91: 7A–11A
   PubMed Web of Science ®Google Scholar
• Longmire AW, Swift LL, Roberts LJ, 2nd, Awad JA, Burk RF, Morrow JD. Effect of oxygen tension on the generation of F2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochem Pharmacol 1994; 47: 1173–1177
   PubMed Web of Science ®Google Scholar
• O'Byrne S, Forte P, Roberts LJ, 2nd, Morrow JD, Johnston A, Anggard E, Leslie RD, Benjamin N. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes 2000; 49: 857–862
   PubMed Web of Science ®Google Scholar
• Griffiths HR, Moller L, Bartosz G, Moller L, Bartosz G, Bast A, Bertoni-Freddari C, Collins A, Cooke M, Coolen S, Haenen G, Hoberg AM, Loft S, Lunec J, Olinski R, Parry J, Pompella A, Poulsen H, Verhagen H, Astley SB. Biomarkers. Mol Asp Med 2002; 23: 101–208
   PubMed Web of Science ®Google Scholar
• Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ, 2nd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Nat Acad Sci USA 1990; 87: 9383–9387
   PubMed Web of Science ®Google Scholar
• Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ, 2nd. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Nat Acad Sci USA 1992; 89: 10721–10725
   PubMed Web of Science ®Google Scholar
• Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ, 2nd. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198–1203
   PubMed Web of Science ®Google Scholar
• Davi G, Alessandrini P, Mezzetti A, Minotti G, Bucciarelli T, Costantini F, Cipollone F, Bon GB, Ciabattoni G, Patrono C. In vivo formation of 8-Epi-prostaglandin F2α is increased in hypercholesterolemia. Arteriosclerosis, Thromb Vasc Biol 1997; 17: 3230–3235
   PubMed Web of Science ®Google Scholar
• Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, Patrono C. In vivo formation of 8-iso-prostaglandin F2α and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation. Circulation 1999; 99: 224–229
   PubMed Web of Science ®Google Scholar
• Keaney JF, Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ. Framingham Study. Obesity and systemic oxidative stress: Clinical correlates of oxidative stress in the Framingham Study. Arteriosclerosis, Thromb Vasc Biol 2003; 23: 434–439
   PubMed Web of Science ®Google Scholar
• Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, Nutini M, Sensi S, Patrono C. Platelet activation in obese women: Role of inflammation and oxidant stress. JAMA 2002; 288: 2008–2014
   PubMed Web of Science ®Google Scholar
• Cipollone F, Ciabattoni G, Patrignani P, Pasquale M, Di Gregorio D, Bucciarelli T, Davi G, Cuccurullo F, Patrono C. Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina. Circulation 2000; 102: 1007–1013
   PubMed Web of Science ®Google Scholar
• Delanty N, Reilly MP, Pratico D, Lawson JA, McCarthy JF, Wood AE, Ohnishi ST, Fitzgerald DJ, FitzGerald GA. 8-epi PGF2α generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 1997; 95: 2492–2499
   PubMed Web of Science ®Google Scholar
• Jenkins PJ, Harper RW, Nestel PJ. Severity of coronary atherosclerosis related to lipoprotein concentration. Br Med J 1978; 2: 388–391
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001; 285: 2486–2497
   PubMed Web of Science ®Google Scholar
• Wilson SH, Best PJ, Lerman LO, Holmes DR, Jr, Richardson DM, Lerman A. Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2α, in experimental hypercholesterolemia. Cardiovasc Res 1999; 44: 601–607
   PubMed Web of Science ®Google Scholar
• Devaraj S, Hirany SV, Burk RF, Jialal I. Divergence between LDL oxidative susceptibility and urinary F(2)-isoprostanes as measures of oxidative stress in type 2 diabetes. Clin Chem 2001; 47: 1974–1979
   PubMed Web of Science ®Google Scholar
• Wang Z, Ciabattoni G, Creminon C, Lawson J, Fitzgerald GA, Patrono C, Maclouf J. Immunological characterization of urinary 8-epi-prostaglandin F2α excretion in man. J Pharmacol Exp Therap 1995; 275: 94–100
   PubMed Web of Science ®Google Scholar
• Basu S. Isoprostanes: Novel bioactive products of lipid peroxidation. Free Radic Res 2004; 38: 105–122
   PubMed Web of Science ®Google Scholar
• Dousset JC, Trouilh M, Foglietti MJ. Plasma malonaldehyde levels during myocardial infarction. Clin Chim Acta 1983; 129: 319–322
   PubMed Web of Science ®Google Scholar
• Loeper J, Goy J, Rozensztajn L, Bedu O, Moisson P. Lipid peroxidation and protective enzymes during myocardial infarction. Clin Chim Acta 1991; 196: 119–125
   PubMed Web of Science ®Google Scholar
• Berg K, Jynge P, Bjerve K, Skarra S, Basu S, Wiseth R. Oxidative stress and inflammatory response during and following coronary interventions for acute myocardial infarction. Free Radic Res 2005; 39(6)629–636
   PubMed Web of Science ®Google Scholar
• Takahashi K, Nammour TM, Fukunaga M, Ebert J, Morrow JD, Roberts LJ, 2nd, Hoover RL, Badr KF. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2α, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Investig 1992; 90: 136–141
   PubMed Web of Science ®Google Scholar
• Hoffman SW, Moore S, Ellis EF. Isoprostanes: Free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke 1997; 28: 844–849
   PubMed Web of Science ®Google Scholar
• Yin K, Halushka PV, Yan YT, Wong PY. Antiaggregatory activity of 8-epi-prostaglandin F2α and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. J Pharmacol Exp Ther 1994; 270: 1192–1196
   PubMed Web of Science ®Google Scholar
• Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brummer J, Gutzki FM, Berger J, Frolich JC, Boger RH. Urinary 8-iso-prostaglandin F2α as a risk marker in patients with coronary heart disease: A matched case-control study. Circulation 2004; 109: 843–848
   PubMed Web of Science ®Google Scholar
• Vassalle C, Botto N, Andreassi MG, Berti S, Biagini A. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis 2003; 14: 213–218
   PubMed Web of Science ®Google Scholar
• Colavitti R, Finkel T. Reactive oxygen species as mediators of cellular senescence. IUBMB: Life 2005; 277–281
   PubMed Web of Science ®Google Scholar
• Ulus AT, Aksoyek A, Ozkan M, Katircioglu SF, Basu S. Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. Free Radic Biol Med 2003; 34(7)911–917
   PubMed Web of Science ®Google Scholar